Quest PharmaTech Company Top Insiders
| QPTFF Stock | USD 0.01 0.00 0.00% |
Quest PharmaTech employs about 11 people. The company is managed by 5 executives with a total tenure of roughly 59 years, averaging almost 11.0 years of service per executive, having 2.2 employees per reported executive. Examination of Quest PharmaTech's management performance can provide insight into the company performance.
| Ragupathy Madiyalakan CEO CEO, Director, Ex-Officio Member of Compensation Committee, Ex-Officio Member of Audit Committee and Ex-Officio Member of Corporate Governance Committee |
| Thomas Woo President Vice President - Product Development |
Quest |
Quest PharmaTech Management Team Effectiveness
Quest PharmaTech's management efficiency ratios could be used to measure how well Quest PharmaTech manages its routine affairs as well as how well it operates its assets and liabilities.Quest PharmaTech Workforce Comparison
Quest PharmaTech is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 1,635. Quest PharmaTech maintains roughly 11.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Quest PharmaTech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Quest PharmaTech Price Series Summation is a cross summation of Quest PharmaTech price series and its benchmark/peer.
Quest PharmaTech Notable Stakeholders
A Quest PharmaTech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quest PharmaTech often face trade-offs trying to please all of them. Quest PharmaTech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quest PharmaTech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ragupathy Madiyalakan | CEO, Director, Ex-Officio Member of Compensation Committee, Ex-Officio Member of Audit Committee and Ex-Officio Member of Corporate Governance Committee | Profile | |
| Thomas Woo | Vice President - Product Development | Profile | |
| Roger Andrews | Head Communications | Profile | |
| Douglas Bachman | VP Devel | Profile | |
| Pierre Vermette | Chief Officer | Profile |
About Quest PharmaTech Management Performance
The success or failure of an entity such as Quest PharmaTech often depends on how effective the management is. Quest PharmaTech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest Pharmatech is traded on OTC Exchange in the United States.
Quest PharmaTech Workforce Analysis
Traditionally, organizations such as Quest PharmaTech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quest PharmaTech within its industry.Quest PharmaTech Manpower Efficiency
Return on Quest PharmaTech Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 7.7M | |
| Net Loss Per Executive | 17M |
Complementary Tools for Quest Pink Sheet analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |